Metabolomics Market

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021

Report Code: BT 2550 Mar, 2017, by marketsandmarkets.com

MarketsandMarkets forecasts the metabolomics market to grow from USD 1.21 billion in 2016 to USD 2.38 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 14.6% during the forecast period. Metabolomics plays a vital role in the fields of toxicity testing, biomarker development, drug discovery, and clinical diagnostics. Factors such as the growing demand for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and rising necessity for toxicology testing are driving the growth of the metabolomics market. Additionally, the potential for metabolomics to move beyond basic research and into the field of diagnostics, by integrating with other omics technologies such as proteomics and transcriptomics, is also supporting the growth of the metabolomics market during the forecast period.

Metabolomics Market-By Region 2021

By product & service, the metabolomics instruments segment is accounted for the largest share of the market

On the basis of products & services, the metabolomics market is segmented into metabolomics instruments and bioinformatics tools and services. In 2015, the metabolomics instruments segment commanded the largest share of the global metabolomics market. This is mainly due to the ability of these instruments to separate and detect the complex structure of metabolites on a large scale, providing quality results. Furthermore, wide usage of these instruments in research activities, increase in funds for research projects, development of innovative technologies in these tools, and their extensive application in the drug discovery process are fueling the growth of this market.

By application, the lung diffusion mixtures segment to accounted for the largest share of the market

Based on applications, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The rising prevalence and incidence of chronic diseases such as cardiac diseases, cancer, and diabetes; growing acceptance of cancer diagnostic tests; and scientific progression in discovery technologies are major factors driving market growth in this segment.

By indication, the hospitals segment accounted for the largest share of the market

Based on indication, the cancer segment accounted for the largest share of the global metabolomics market, in 2015. The large share of this segment can be attributed to the increasing utility of biomarkers in patient stratification and the drug development process and increasing scientific progression in discovery technologies.

APAC to grow at the highest CAGR during the forecast period.

North America is expected to hold the largest market size in the metabolomics market during the forecast period, followed by the European region. On the other hand, the Asia Pacific market is expected to witness the highest growth during the forecast period. Growth in this region can be attributed to the huge demand for metabolomics in drug discovery and biomarker development experiments. Factors such as significant growth in the life science industry, increasing investments by global players over the past few years, and increasing number of tie-ups between manufacturers and institutions in this region are also expected to support market growth in this region.

Metabolomics Market

Market Dynamics

Driver: Growing demand for personalized medicine

Personalized medicine is a technology-based and patient-centered customization of diagnosis and treatment evaluation. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time. Such developments are opening new opportunities for the utilization of metabolomics in the development of personalized and precision medicine. As metabolomics precisely differentiates between two or more disease phenotypes, it can be applied to identify metabolites and biomarkers related to the perturbation being investigated by providing detailed cellular information. These metabolites can be used to develop personalized prognostic, diagnostic, and treatment approaches for monitoring of disease progression, treatment efficacy, predisposition to drug-related side effects, and potential relapse. The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Also, market players are also focusing on strategic collaborations and partnerships to augment the use of metabolomics in the field of personalized medicine. Moreover, pharmacometabonomics and pharmacokinetics are two new technologies concerned with the analysis of pre-dose metabolite profiles for predicting drug response prior to dosing. Considering such significant developments in the field of metabolomics, coupled with the increasing focus of industry participants to leverage the advantages of metabolomics approaches in the development of personalized medicine, the market is expected to witness significant growth in the coming years.

Restraint: Issues related to data examination and processing

Metabolomic techniques produce a very large volume of data as they create millions of data points per second over a ten-minute or longer analysis. Continuous growth in the generation of high-volume heterogeneous data is increasing data complexity, and it is becoming increasingly difficult to evaluate all these data points in an effective manner. Moreover, due to the chemical diversity of small molecule metabolites, it is impossible to study the entire metabolome using a single analytical technique. As a result, the data produced is not only complex but also leads to a proportionate increase in the demand for physical storage, correct and rigorous analysis, and suitable software/databases for visualization. Thus, the high complexity of data generated during life science research and the difficulty in managing it is hindering the growth of the metabolomics market.

Opportunity: Biomarker development

Metabolomics is used for the identification of new biomarkers through the use of bioinformatics tools, which indicate the changes in the physiological state of a cell or tissue. Biomarkers are important for the development of in vitro diagnostic tools, environmental toxicology screening methods, and drug discovery and development techniques. The omics revolution of the last decade has increased the application of metabolomics in biomedical research. As a result of these technological developments, new biomarkers are being regularly discovered. These biomarkers are required in medical sciences to better define and diagnose diseases, predict adverse drug events, and identify patient groups who would benefit from certain treatments. Moreover, in the near future, the identification of biomarkers related to the safety, sensitivity, and resistance to commercially available drugs will present significant growth opportunities for the metabolomics market.

Challenge: Complexity and diversity of biological samples

Omics technologies such as proteomics, genomics, and transcriptomics have well-established platforms to translate research findings into meaningful outcomes. However, in the study metabolites, the profiling of metabolomes is hampered by their diversity, variation of metabolite concentration, and their interdependence on complex biochemical factors. This creates several complications in standardizing any experiment. Moreover, designing protocols for sample preparation, identification, and standardization, and then translating results into meaningful data is a challenging task. As a result, currently, there is a growing need for improvements in both targeted and non-targeted metabolomics studies. However, the continuous developments in this field and growing number of R&D activities have the potential to provide the overall information on a complex biological network. This, in turn, can overcome the challenges posed by the complexity and diversity of biological samples in metabolomics.

Metabolomics Market-By Region 2021

Scope of the Report

Report Metric

Details

Market size available for years

2014–2021

Base year considered

2015

Forecast period

2016–2021

Forecast units

Value (USD)

Segments covered

Product & Service, Application, Indication, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Agilent Technologies, Inc. (US), Bio- Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), LECO Corporation (US), Biocrates Life Sciences AG (Austria), Metabolon, Inc. (US), and Human Metabolome Technologies, Inc. (Japan)

The research report categorizes the metabolomics market to forecast the revenues and analyze the trends in each of the following sub-segments:

Global Metabolomics Market, by Product & Service

  • Metabolomic Instruments
    • Separation Techniques
      • Gas Chromatography (GC)
      • Capillary Electrophoresis (CE)
      • High-performance Liquid Chromatography (HPLC)
      • Ultra-performance Liquid Chromatography (UPLC)
    • Detection Techniques
      • Nuclear Magnetic Resonance Spectroscopy (NMR)
      • Mass Spectrometry (MS)
      • Surface-based Mass Analysis
  • Metabolomic Bioinformatics Tools and Services
    • Bioinformatics Tools & Database
    • Bioinformatics Services

Global Metabolomics Market, by Application

  • Biomarker Discovery      
  • Drug Discovery/Drug Assessment           
  • Nutrigenomics  
  • Toxicology Testing      
  • Personalized Medicine
  • Functional Genomics
  • Other Applications      

Global Metabolomics Market, by Indication

  • Cancer
  • Cardiovascular Disorders           
  • Neurological disorders
  • Inborn Errors of Metabolism
  • Other Indications          

Global Metabolomics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Russia
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East and Africa

Key Market Players

In 2015, Thermo Fisher Scientific accounted for the largest share of the global metabolomics market. Thermo Fisher provides a wide range of GC, LC, GC-MS, LC-MS, NMR spectrometer, and bioinformatics tools for metabolite analysis. The Analytical Technologies business segment of the company provides metabolomics solutions. The company has a strong presence in the US, which is the largest market for metabolomics. The company strategically invests in acquisitions, collaborations, and product innovations to increase its portfolio for mass spectrometry and chromatography.

Recent Developments

  • In December 2016, Shimadzu launched the NOA-7100 transportable NOx-O2 analyzer for quantifying nitrogen oxides (NOx) and oxygen (O2) concentration in real time. This launch enhanced the company’s portfolio.
  • In December 2016, Agilent Technologies collaborated with Transcriptic Inc. (U.S.), a robotic cloud-based biotechnology laboratory, to develop and provide rapid and efficient technologies for broad scale synthetic and discovery. This collaboration helped Agilent enhance its market position by serving a global customer base with automated and robotics workflows for bioreagent optimization.
  • In November 2016, Waters Corporation launched CORTECS T3 and CORTECS Shield RP18 column chemistries. These columns provide speed, selectivity, and sensitivity in UPLC, UHPLC, and HPLC separations. This launch expanded the company’s customer base for the CORTECS Columns product line.
  • In November 2016, Agilent Technologies opened a technology center in Folsom, California, U.S., for providing scientific consumables and supplies, especially chromatography consumables and hardware. This helped the company to offer productive, efficient, and high quality solutions to analytical laboratories.
  • In September 2016, Thermo Fisher Scientific opened its new global headquarters in Massachusetts, U.S. The facility helps the company to cater to a larger customer base.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends in the metabolomics market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 25)
    1.1 Objectives of the Study
    1.2 Metabolomics Market Definition
    1.3 Market Scope
           1.3.1 Metabolomics Technology Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 29)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Metabolomics Market Size Estimation
    2.3 Metabolomics Technology Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 47)
    4.1 Metabolomics Market Overview
    4.2 Asia-Pacific: Metabolomics Separation Tools Market, By Type
    4.3 Geographic Snapshot: Market
    4.4 Geographic Mix: Market
    4.5 Metabolomics Market: Developing vs Developed Markets

5 Metabolomics Market Overview (Page No. - 52)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Metabolomics Market Drivers
                    5.2.1.1 Availability of Government and Private Funding
                    5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
                    5.2.1.3 Technological Advancements
                    5.2.1.4 Growing Demand for Personalized Medicine
                    5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
           5.2.2 Key Market Restraints
                    5.2.2.1 Issues Related to Data Examination and Processing
                    5.2.2.2 High Cost of Tools and Instruments
           5.2.3 Key Market Opportunities
                    5.2.3.1 Biomarker Development
                    5.2.3.2 Rapid Growth Opportunities in Emerging Markets
           5.2.4 Key Challenges
                    5.2.4.1 Complexity and Diversity of Biological Samples
                    5.2.4.2 Dearth of Skilled Researchers

6 Industry Insights (Page No. - 63)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Increasing Adoption of Hyphenated Technologies
           6.2.2 Tie-Ups Between Instrument Manufacturers and Research Laboratories/Academic Institutions
    6.3 Regulatory Analysis

7 Technology Investment Potential (Page No. - 67)
    7.1 Introduction
    7.2 Investment Client Networks
    7.3 Funding Bodies/Initiatives (2012–2016)
    7.4 Analysis of Potential Areas for Technology Investment Using Strategic Evaluation
           7.4.1 Parameters Considered for Emerging Opportunity Evaluation
                    7.4.1.1 Level of Attractiveness
                    7.4.1.2 Probability of Success
           7.4.2 Opportunity Strategic Evaluation Analysis
           7.4.3 Description of Opportunities
                    7.4.3.1 Viable (Quadrant 1) – Biomarker Discovery and Lead Optimization in Drug Discovery
                               7.4.3.1.1 Biomarker Discovery
                               7.4.3.1.2 Lead Optimization in Drug Discovery
                               7.4.3.1.3 Toxicity Testing
                    7.4.3.2 Promising (Quadrant 2) – Companion Diagnostics for Personalized Medicine and Nutrigenomics
                               7.4.3.2.1 Companion Diagnostics for Personalized Medicine
                               7.4.3.2.2 Nutrigenomics
                               7.4.3.2.3 Agriculture
                    7.4.3.3 Challenging (Quadrant 3) – Environmental Metabolomics
                               7.4.3.3.1 Environmental Metabolomics
                               7.4.3.3.2 Functional Genomics

8 Global Metabolomics Market, By Product and Service (Page No. - 74)
    8.1 Introduction
    8.2 Metabolomics Instruments
           8.2.1 Separation Tools
                    8.2.1.1 High-Performance Liquid Chromatography
                    8.2.1.2 Gas Chromatography
                    8.2.1.3 Ultra-Performance Liquid Chromatography
                    8.2.1.4 Capillary Electrophoresis
           8.2.2 Detection Tools
                    8.2.2.1 Mass Spectrometry
                    8.2.2.2 Nuclear Magnetic Resonance Spectroscopy
                    8.2.2.3 Surface-Based Mass Analysis
    8.3 Metabolomics Bioinformatics Tools and Services
           8.3.1 Bioinformatics Tools & Databases
           8.3.2 Bioinformatics Services

9 Global Metabolomics Market, By Application (Page No. - 99)
    9.1 Introduction
    9.2 Biomarker Discovery
    9.3 Drug Discovery
    9.4 Toxicology Testing
    9.5 Nutrigenomics
    9.6 Functional Genomics
    9.7 Personalized Medicine
    9.8 Other Applications

10 Global Metabolomics Market, By Indication (Page No. - 111)
     10.1 Introduction
     10.2 Cancer
     10.3 Cardiovascular Disorders
     10.4 Neurological Disorders
     10.5 Inborn Errors of Metabolism
     10.6 Other Indications

11 Global Metabolomics Market, By Region (Page No. - 121)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of APAC
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 199)
     12.1 Overview
     12.2 Product Portfolio Analysis
     12.3 Metabolomics Market Share Analysis
     12.4 Competitive Situations and Trends
             12.4.1 Product Launches and Enhancements
             12.4.2 Partnerships, Agreements, Collaborations, and Alliances
             12.4.3 Expansions
             12.4.4 Acquisitions and Divestitures

13 Company Profiles (Page No. - 207)
     13.1 Introduction
     13.2 Thermo Fisher Scientific Inc.
             13.2.1 Business Overview
             13.2.2 Products & Services Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Agilent Technologies, Inc.
             13.3.1 Business Overview
             13.3.2 Products & Services Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Waters Corporation
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Danaher Corporation
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Shimadzu Corporation
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 Biocrates Life Sciences AG
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
     13.8 Bio-Rad Laboratories, Inc.
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Bruker Corporation
             13.9.1 Business Overview
             13.9.2 Products & Services Offered
             13.9.3 Recent Developments
     13.10 Human Metabolome Technologies, Inc.
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Leco Corporation
             13.11.1 Business Overview
             13.11.2 Products Offered
             13.11.3 Recent Developments
     13.12 Metabolon, Inc.
             13.12.1 Business Overview
             13.12.2 Products Offered
             13.12.3 Recent Developments

14 Appendix (Page No. - 259)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports


List of Tables (188 Tables)

Table 1 Global Metabolomics Market Snapshot
Table 2 Availability of Government and Private Funding to Drive the Market Growth
Table 3 Issues Related to Data Examination and Processing to Restrain Market Growth
Table 4 Biomarker Development to Offer Significant Opportunities for Metabolomics Technology Market Growth
Table 5 Dearth of Skilled Researchers is A Major Challenge in the Metabolomics Market
Table 6 Regulatory Standard/Approval Required for Metabolomics Products, By Country/Region
Table 7 Global Market Size, By Product & Service, 2014–2021 (USD Million)
Table 8 Global Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 9 Global Metabolomics Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Metabolomics Separation Tools Market Size, By Type, 2014–2021 (USD Million)
Table 11 Global Metabolomics Separation Tools Market Size, By Country, 2014–2021 (USD Million)
Table 12 Global High-Performance Liquid Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 13 Global Gas Chromatography Size, By Country, 2014–2021 (USD Million)
Table 14 Global Ultra-Performance Liquid Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 15 Global Capillary Electrophoresis Market Size, By Country, 2014–2021 (USD Million)
Table 16 Global Metabolomics Detection Tools Market Size, By Type, 2014–2021 (USD Million)
Table 17 Global Metabolomics Detection Tools Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Mass Spectrometry Market Size, By Country, 2014–2021 (USD Million)
Table 19 Global Nuclear Magnetic Resonance Spectroscopy Market Size, By Country, 2014–2021 (USD Million)
Table 20 Global Surface-Based Mass Analysis Market Size, By Country, 2014–2021 (USD Million)
Table 21 Global Metabolomics Bioinformatics Tools and Services Market Size, By Type, 2014–2021 (USD Million)
Table 22 Global Metabolomics Bioinformatics Tools and Services Market Size, By Country, 2014–2021 (USD Million)
Table 23 Global Bioinformatics Tools & Databases Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global Bioinformatics Services Market Size, By Country, 2014–2021 (USD Million)
Table 25 Global Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 26 Global Metabolomics Technology Market Size for Biomarker Discovery Applications, By Country, 2014–2021 (USD Million)
Table 27 Global Market Size for Drug Discovery Applications, By Country, 2014–2021 (USD Million)
Table 28 Global Metabolomics Technology Market Size for Toxicology Testing Applications, By Country, 2014-2021 (USD Million)
Table 29 Global Metabolomics Market Size for Nutrigenomic Applications, By Country, 2014-2021 (USD Million)
Table 30 Global Market Size for Functional Genomic Applications, By Country, 2014-2021 (USD Million)
Table 31 Global Market Size for Personalized Medicine Applications, By Country, 2014-2021 (USD Million)
Table 32 Global Metabolomics Technology Market Size for Other Applications, By Country, 2014-2021 (USD Million)
Table 33 Global Market Size, By Indication, 2014–2021 (USD Million)
Table 34 Global Metabolomics Market Size for Cancer, By Country, 2014–2021 (USD Million)
Table 35 Global Market Size for Cardiovascular Disorders, By Country, 2014–2021 (USD Million)
Table 36 Global Market Size for Neurological Disorders, By Country, 2014-2021 (USD Million)
Table 37 Global Metabolomics Market Size for Inborn Errors of Metabolism, By Country, 2014-2021 (USD Million)
Table 38 Global Market Size for Other Indications, By Country, 2014-2021 (USD Million)
Table 39 Global Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 41 North America: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 42 North America: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 43 North America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 44 North America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 45 North America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 47 North America: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 48 U.S.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 49 U.S.: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 50 U.S.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 51 U.S.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 52 U.S.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 53 U.S.: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 54 U.S.: Metabolomics Technology Market Size, By Indication, 2014–2021 (USD Million)
Table 55 Canada: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 56 Canada: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 57 Canada: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 58 Canada: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 59 Canada: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 60 Canada: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 61 Canada: Metabolomics Technology Market Size, By Indication, 2014–2021 (USD Million)
Table 62 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 63 Europe: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 64 Europe: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 65 Europe: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 66 Europe: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 67 Europe: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 68 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 69 Europe: Market Size, By Indication, 2014–2021 (USD Million)
Table 70 Germany: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 71 Germany: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 72 Germany: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 73 Germany: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 74 Germany: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 75 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 76 Germany: Market Size, By Indication, 2014–2021 (USD Million)
Table 77 U.K.: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 78 U.K.: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 79 U.K.: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 80 U.K.: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 81 U.K.: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 82 U.K.: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 83 U.K.: Market Size, By Indication, 2014–2021 (USD Million)
Table 84 France: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 85 France: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 86 France: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 87 France: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 88 France: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 89 France: Market Size, By Application, 2014–2021 (USD Million)
Table 90 France: Market Size, By Indication, 2014–2021 (USD Million)
Table 91 Italy: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 92 Italy: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 93 Italy: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 94 Italy: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 95 Italy: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 96 Italy: Market Size, By Application, 2014–2021 (USD Million)
Table 97 Italy: Metabolomics Market Size, By Indication, 2014–2021 (USD Million)
Table 98 Spain: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 99 Spain: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 100 Spain: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 101 Spain: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 102 Spain: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 103 Spain: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 104 Spain: Market Size, By Indication, 2014–2021 (USD Million)
Table 105 Rest of Europe: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 106 RoE: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 107 RoE: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 108 RoE: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 109 RoE: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 110 RoE: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 111 RoE: Market Size, By Indication, 2014–2021 (USD Million)
Table 112 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Million)
Table 113 Asia-Pacific: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 114 Asia-Pacific: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 115 Asia-Pacific: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 116 Asia-Pacific: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 117 Asia-Pacific: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 118 Asia-Pacific: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 119 Asia-Pacific: Market Size, By Indication, 2014–2021 (USD Million)
Table 120 Japan: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 121 Japan: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 122 Japan: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 123 Japan: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 124 Japan: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 125 Japan: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 126 Japan: Market Size, By Indication, 2014–2021 (USD Million)
Table 127 China: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 128 China: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 129 China: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 130 China: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 131 China: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 132 China: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 133 China: Market Size, By Indication, 2014–2021 (USD Million)
Table 134 India: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 135 India: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 136 India: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 137 India: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 138 India: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 139 India: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 140 India: Market Size, By Indication, 2014–2021 (USD Million)
Table 141 RoAPAC: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 142 RoAPAC: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 143 RoAPAC: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 144 RoAPAC: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 145 RoAPAC: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 146 RoAPAC: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 147 RoAPAC: Market Size, By Indication, 2014–2021 (USD Million)
Table 148 Latin America: Market Size, By Country, 2014–2021 (USD Million)
Table 149 Latin America: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 150 Latin America: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 151 Latin America: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 152 Latin America: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 153 Latin America: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 154 Latin America: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 155 Latin America: Market Size, By Indication, 2014–2021 (USD Million)
Table 156 Brazil: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 157 Brazil: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 158 Brazil: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 159 Brazil: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 160 Brazil: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 161 Brazil: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 162 Brazil: Market Size, By Indication, 2014–2021 (USD Million)
Table 163 Mexico: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 164 Mexico: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 165 Mexico: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 166 Mexico: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 167 Mexico: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 168 Mexico: Market Size, By Indication, 2014–2021 (USD Million)
Table 169 RoLA: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 170 RoLA: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 171 RoLA: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 172 RoLA: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 173 RoLA: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 174 RoLA: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 175 RoLA: Market Size, By Indication, 2014–2021 (USD Million)
Table 176 Middle East & Africa: Metabolomics Market Size, By Product & Service, 2014–2021 (USD Million)
Table 177 Middle East & Africa: Metabolomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 178 Middle East & Africa: Metabolomics Instruments Market Size for Separation Tools, By Type, 2014–2021 (USD Million)
Table 179 Middle East & Africa: Metabolomics Instruments Market Size for Detection Tools, By Type, 2014–2021 (USD Million)
Table 180 Middle East & Africa: Metabolomics Bioinformatics Tools & Services Market Size, By Type, 2014–2021 (USD Million)
Table 181 Middle East & Africa: Metabolomics Market Size, By Application, 2014–2021 (USD Million)
Table 182 Middle East & Africa: Market Size, By Indication, 2014–2021 (USD Million)
Table 183 Growth Strategy Matrix (January 2013–November 2016)
Table 184 Product Portfolio Analysis: Metabolomics Market
Table 185 Product Launches and Enhancements, 2013–2016
Table 186 Partnerships, Agreements, Collaborations, and Alliances, 2013–2016
Table 187 Expansions, 2013–2016
Table 188 Acquisitions and Divestitures, 2013–2016


List of Figures (42 Figures)

Figure 1 Global Metabolomics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Metabolomics Market, By Product & Service, 2016 vs 2021 (USD Million)
Figure 7 Global Metabolomics Instruments Market, By Type, 2016 vs 2021 (USD Million)
Figure 8 Global Metabolomics Separation Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Metabolomics Detection Tools Market, By Type, 2016 vs 2021 (USD Million)
Figure 10 Global Metabolomics Market for Bioinformatics Tools and Services, By Type, 2016 vs 2021 (USD Million)
Figure 11 Global Market, By Application, 2016 vs 2021 (USD Million)
Figure 12 Global Metabolomics Market, By Indication, 2016 vs 2021 (USD Million)
Figure 13 Asia-Pacific to Register Highest Growth During the Forecast Period
Figure 14 Availability of Government and Private Funding for Research is Driving Growth of the Metabolomics Market
Figure 15 HPLC Commanded the Largest Share of the Asia-Pacific Metabolomics Separation Tools Market in 2015
Figure 16 U.S. Dominated the Global Metabolomics Market in 2015
Figure 17 Asia-Pacific to Register the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register Higher Growth During the Forecast Period
Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 R&D Expenditure of Top Biotechnology and Pharmaceutical Companies, By Geography, 2012–2014
Figure 21 Global Metabolomics Market- Investment Client Network
Figure 22 Opportunity Strategic Evaluation Analysis of Metabolomics in Various Applications Areas
Figure 23 Metabolomics Instruments Dominated the Market in 2016
Figure 24 Biomarker Discovery to Dominate the Metabolomics Applications Market in 2016
Figure 25 Cancer Indication to Dominate the Market in 2016
Figure 26 Global Market: Geographical Snapshot
Figure 27 North America: Market Snapshot
Figure 28 Europe: Market Snapshot
Figure 29 Asia-Pacific: Market Snapshot
Figure 30 Key Developments in the Market, 2013–2016
Figure 31 Global Metabolomics Market Share Analysis, By Key Player, 2015
Figure 32 Battle for Market Share: Product Launches & Enhancements Was the Key Growth Strategy Adopted By Market Players
Figure 33 Geographic Revenue Mix of the Major Players in the Metabolomics Market
Figure 34 Thermo Fisher Scientific Inc.: Company Snapshot (2015)
Figure 35 Company Snapshot: Agilent Technologies, Inc.: (2015)
Figure 36 Waters Corporation: Company Snapshot (2015)
Figure 37 Danaher Corporation: Company Snapshot (2015)
Figure 38 Shimadzu Corporation: Company Snapshot (2015)
Figure 39 Bio-Rad Laboratories, Inc.: Company Snapshot (2015)
Figure 40 Bruker Corporation: Company Snapshot (2015)
Figure 41 Marketsandmarkets Knowledge Store Snapshot
Figure 42 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot

The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving a metabolomics technology market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, issues related to data examination and processing and high-cost tools and instruments and their maintenance are the major restraining factors for this market.

The report analyzes the market by product & service, application, indication, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global metabolomics technology market and its submarkets. Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics bioinformatics tools & services is expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Asia pacific region showcase high growth potential for Metabolomics Market

The Asia-Pacific region represents the most lucrative healthcare market and growth in the metabolomics research base in APAC countries is expected to increase the uptake of metabolomics technologies in the healthcare industry in this region. Additionally, the growing population in countries like China and India, rapid growth in geriatric population, improving healthcare infrastructure, growing per capita income, and rising focus of key market players on emerging APAC countries are driving the growth of this market. According to the Economist Intelligence Unit (EIU), healthcare spending in APAC is expected to grow at a rate of 7.1% from 2013 to 2017.This market forms one of the most promising metabolomics technology markets in the world accounting for the fastest growth rate during the forecast period. This in turn will create significant growth potential for market in APAC region over the coming years.

Metabolomics Market-By Region 2021

Growing Demand for Personalized Medicine Drive the Metabolomics Market

The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time. Such developments are opening new opportunities for the utilization of metabolomics in the development of personalized and precision medicine. Considering significant developments in the field of metabolomics, coupled with the increasing focus of industry participants to leverage the advantages of metabolomics approaches in the development of personalized medicine, the market is expected to witness significant growth in the coming years.

The global metabolomics technology market is highly competitive and fragmented in nature. Prominent players in the global Metabolomics Market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.). A majority of the leading players in this market are based in developed countries across North America and Europe.

Key Questions

  • Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
  • How growing demand for personalized medicine and other factors would change the future of market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

COVID-19

Get in-depth analysis of the COVID-19 impact on the Metabolomics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Metabolomics Market

Request For Special Pricing
Report Code
BT 2550
Published ON
Mar, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Metabolomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home